Objectives

After participating in this educational activity, attendees should be able to:

1| Discuss cocaine use disorder and its impact nationally and statewide.
2| Review the current pharmacotherapy available for cocaine use disorder.
3| Evaluate the efficacy of buprenorphine-naloxone and naltrexone in treating cocaine use disorder.
4| Apply literature to clinical practice as appropriate

 

Presenter(s): 
Kathryn Higgins, PharmD
PGY1 Community Based Pharmacy Resident
Baystate Medical Center
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Kathryn Higgins, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
02/03/2025 - 2:00pm to 3:00pm EST
  • 1.00 ACPE Contact Hours

Please login or register to take this course.